DalsnaFinance › Analyst accuracy › Stifel › FHTX target
Stifel cuts Foghorn Therapeutics stock price target on pipeline shift
Stifel lowered its price target on Foghorn Therapeutics Inc. shares (NASDAQ:FHTX) to $5.00 from $12.00 while maintaining a Buy rating on the stock.
A fact about what Stifel published, as reported by Investing.com, not a recommendation from Dalsna Finance; Stifel is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.